%20--%3E%3Cmetadata%20xmlns%3Ardf%3D%22http%3A%2F%2Fwww.w3.org%2F1999%2F02%2F22-rdf-syntax-ns%23%22%20xmlns%3Axsi%3D%22http%3A%2F%2Fwww.w3.org%2F2001%2FXMLSchema-instance%22%20xmlns%3Adc%3D%22http%3A%2F%2Fpurl.org%2Fdc%2Felements%2F1.1%2F%22%20xmlns%3Adcterms%3D%22http%3A%2F%2Fpurl.org%2Fdc%2Fterms%2F%22%3E%3Crdf%3ARDF%3E%3Crdf%3ADescription%3E%3Cdc%3Atitle%3EShadows%3C%2Fdc%3Atitle%3E%3Cdc%3Acreator%3EDiceBear%3C%2Fdc%3Acreator%3E%3Cdc%3Asource%20xsi%3Atype%3D%22dcterms%3AURI%22%3Ehttps%3A%2F%2Fwww.dicebear.com%3C%2Fdc%3Asource%3E%3Cdcterms%3Alicense%20xsi%3Atype%3D%22dcterms%3AURI%22%3Ehttps%3A%2F%2Fcreativecommons.org%2Fpublicdomain%2Fzero%2F1.0%2F%3C%2Fdcterms%3Alicense%3E%3Cdc%3Arights%3E%E2%80%9CShadows%E2%80%9D%20(https%3A%2F%2Fwww.dicebear.com)%20by%20%E2%80%9CDiceBear%E2%80%9D%2C%20licensed%20under%20%E2%80%9CCC0%201.0%E2%80%9D%20(https%3A%2F%2Fcreativecommons.org%2Fpublicdomain%2Fzero%2F1.0%2F)%3C%2Fdc%3Arights%3E%3C%2Frdf%3ADescription%3E%3C%2Frdf%3ARDF%3E%3C%2Fmetadata%3E%3Cdefs%3E%3Cg%20id%3D%22shoulders-wide-d377ad84%22%3E%3Cpath%20d%3D%22M0%2050C0%2017%2017.55%203%2039%203s39%2014%2039%2047Z%22%20fill%3D%22%23733662%22%2F%3E%3C%2Fg%3E%3Cg%20id%3D%22tops-curls-d377ad84%22%3E%3Cg%3E%3Ccircle%20cx%3D%2210.52%22%20cy%3D%2225.5%22%20r%3D%227%22%20fill%3D%22%23733662%22%2F%3E%3Ccircle%20cx%3D%2218.5%22%20cy%3D%2216.95%22%20r%3D%227.5%22%20fill%3D%22%23733662%22%2F%3E%3Ccircle%20cx%3D%2228.95%22%20cy%3D%2215.05%22%20r%3D%227.5%22%20fill%3D%22%23733662%22%2F%3E%3Ccircle%20cx%3D%2239.4%22%20cy%3D%2217.9%22%20r%3D%227.5%22%20fill%3D%22%23733662%22%2F%3E%3Ccircle%20cx%3D%2246.05%22%20cy%3D%2226.45%22%20r%3D%227%22%20fill%3D%22%23733662%22%2F%3E%3C%2Fg%3E%3C%2Fg%3E%3Cg%20id%3D%22heads-round-d377ad84%22%3E%3Cuse%20transform%3D%22translate(3%203)%20rotate(-3%2C%2028%2C%2025)%22%20href%3D%22%23tops-curls-d377ad84%22%2F%3E%3Ccircle%20cx%3D%2231%22%20cy%3D%2238%22%20r%3D%2219%22%20fill%3D%22%23733662%22%2F%3E%3C%2Fg%3E%3CclipPath%20id%3D%22clip-d377ad84%22%3E%3Crect%20width%3D%22100%22%20height%3D%22100%22%20rx%3D%220%22%20ry%3D%220%22%2F%3E%3C%2FclipPath%3E%3C%2Fdefs%3E%3Cg%20clip-path%3D%22url(%23clip-d377ad84)%22%3E%3Crect%20width%3D%22100%22%20height%3D%22100%22%20fill%3D%22%23ede3e9%22%2F%3E%3Cuse%20transform%3D%22translate(11%2051)%22%20href%3D%22%23shoulders-wide-d377ad84%22%2F%3E%3Cuse%20transform%3D%22translate(19%201)%22%20href%3D%22%23heads-round-d377ad84%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
A type of targeted chemotherapy developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in patients with advanced endometrial cancer. https://www.statnews.com/2026/10/26/merck-kelun-sac-tmt-endometrial-cancer-study-esmo-2026/
statnews.comMerck ADC drug cut risk of death by one-third in advanced endometrial cancerA Phase 3 trial of a targeted drug developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in patients with advanced endometrial cancer.
2 reposts13 likes